Berkeley Research Group is reportedly selling its subsidiary Second Sight Solutions, Axios Pro recently reported.

BRG Reportedly Selling 340B Subsidiary Second Sight Solutions 

Washington, D.C.-based consulting firm Berkeley Research Group (BRG) is reportedly selling its 340B drug industry vendor, which runs both a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
LinkedIn

Site Footer Live